ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/27 | 4,702 | 4,742 | 4,677 | 4,742 | +31 | +0.7% | 178,800 |
2024/12/26 | 4,698 | 4,720 | 4,686 | 4,711 | +36 | +0.8% | 124,300 |
2024/12/25 | 4,690 | 4,698 | 4,611 | 4,675 | -51 | -1.1% | 239,200 |
2024/12/24 | 4,701 | 4,746 | 4,698 | 4,726 | ±0 | ±0% | 186,200 |
2024/12/23 | 4,800 | 4,847 | 4,696 | 4,726 | -121 | -2.5% | 356,700 |
2024/12/20 | 4,800 | 4,856 | 4,776 | 4,847 | +78 | +1.6% | 212,800 |
2024/12/19 | 4,722 | 4,790 | 4,720 | 4,769 | -23 | -0.5% | 181,400 |
2024/12/18 | 4,860 | 4,880 | 4,757 | 4,792 | -46 | -1% | 212,800 |
2024/12/17 | 4,825 | 4,880 | 4,815 | 4,838 | +6 | +0.1% | 129,900 |
2024/12/16 | 4,878 | 4,900 | 4,829 | 4,832 | -37 | -0.8% | 199,300 |
2024/12/13 | 4,770 | 4,886 | 4,766 | 4,869 | +45 | +0.9% | 223,800 |
2024/12/12 | 4,828 | 4,877 | 4,819 | 4,824 | +22 | +0.5% | 208,500 |
2024/12/11 | 4,792 | 4,825 | 4,777 | 4,802 | -2 | ±0% | 139,000 |
2024/12/10 | 4,909 | 4,918 | 4,779 | 4,804 | -78 | -1.6% | 210,800 |
2024/12/09 | 4,895 | 4,920 | 4,861 | 4,882 | +14 | +0.3% | 158,000 |
2024/12/06 | 4,883 | 4,904 | 4,827 | 4,868 | -22 | -0.4% | 148,300 |
2024/12/05 | 4,929 | 4,933 | 4,875 | 4,890 | -5 | -0.1% | 171,900 |
2024/12/04 | 4,896 | 4,939 | 4,833 | 4,895 | -39 | -0.8% | 244,500 |
2024/12/03 | 4,960 | 4,999 | 4,915 | 4,934 | +44 | +0.9% | 276,100 |
2024/12/02 | 4,961 | 4,999 | 4,886 | 4,890 | +69 | +1.4% | 368,100 |
2024/11/29 | 4,855 | 4,869 | 4,821 | 4,821 | -24 | -0.5% | 128,500 |
2024/11/28 | 4,809 | 4,867 | 4,809 | 4,845 | +48 | +1% | 178,500 |
2024/11/27 | 4,822 | 4,835 | 4,751 | 4,797 | -39 | -0.8% | 218,700 |
2024/11/26 | 4,770 | 4,870 | 4,770 | 4,836 | +85 | +1.8% | 222,000 |
2024/11/25 | 4,878 | 4,888 | 4,751 | 4,751 | -107 | -2.2% | 242,800 |
2024/11/22 | 4,804 | 4,861 | 4,774 | 4,858 | +35 | +0.7% | 158,500 |
2024/11/21 | 4,920 | 4,944 | 4,815 | 4,823 | -64 | -1.3% | 201,000 |
2024/11/20 | 4,942 | 4,950 | 4,850 | 4,887 | -34 | -0.7% | 158,500 |
2024/11/19 | 4,752 | 4,936 | 4,708 | 4,921 | +144 | +3% | 288,500 |
2024/11/18 | 4,760 | 4,809 | 4,747 | 4,777 | -23 | -0.5% | 234,900 |
2024/11/15 | 4,884 | 4,915 | 4,792 | 4,800 | -84 | -1.7% | 329,100 |
2024/11/14 | 4,862 | 4,912 | 4,833 | 4,884 | -25 | -0.5% | 189,600 |
2024/11/13 | 4,906 | 4,946 | 4,853 | 4,909 | -45 | -0.9% | 215,300 |
2024/11/12 | 5,000 | 5,049 | 4,898 | 4,954 | +89 | +1.8% | 475,600 |
2024/11/11 | 4,862 | 4,933 | 4,804 | 4,865 | +73 | +1.5% | 312,500 |
2024/11/08 | 4,890 | 4,948 | 4,729 | 4,792 | -168 | -3.4% | 702,100 |
2024/11/07 | 4,929 | 4,995 | 4,811 | 4,960 | +40 | +0.8% | 777,200 |
2024/11/06 | 4,862 | 4,968 | 4,825 | 4,920 | +60 | +1.2% | 248,700 |
2024/11/05 | 4,670 | 4,878 | 4,620 | 4,860 | -20 | -0.4% | 448,400 |
2024/11/01 | 4,932 | 5,000 | 4,870 | 4,880 | -127 | -2.5% | 234,300 |
2024/10/31 | 5,092 | 5,097 | 4,971 | 5,007 | -63 | -1.2% | 322,300 |
2024/10/30 | 5,049 | 5,116 | 5,034 | 5,070 | +47 | +0.9% | 900,600 |
2024/10/29 | 4,972 | 5,037 | 4,910 | 5,023 | +73 | +1.5% | 333,000 |
2024/10/28 | 4,918 | 4,972 | 4,880 | 4,950 | +48 | +1% | 235,800 |
2024/10/25 | 4,887 | 4,910 | 4,834 | 4,902 | -21 | -0.4% | 318,100 |
2024/10/24 | 4,859 | 4,934 | 4,833 | 4,923 | +27 | +0.6% | 232,500 |
2024/10/23 | 4,911 | 4,959 | 4,889 | 4,896 | -16 | -0.3% | 158,600 |
2024/10/22 | 4,896 | 4,934 | 4,890 | 4,912 | -10 | -0.2% | 277,800 |
2024/10/21 | 4,893 | 4,937 | 4,858 | 4,922 | +35 | +0.7% | 304,200 |
2024/10/18 | 4,905 | 4,930 | 4,882 | 4,887 | +6 | +0.1% | 229,000 |
101~
150
件表示中 / 3711件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 335,500円 | +3.8% | -19.9% | 4.05% | 10.97倍 | 0.84倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 409,100円 | +5.8% | +1.2% | 2.93% | 13.57倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,500円 | -11.0% | +206.6% | 0.00% | 8.00倍 | 1.89倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 355,000円 | +8.0% | -15.3% | 3.49% | 9.97倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 322,000円 | - | - | 0.00% | - | 149.14倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム